云南白药(000538) - 2025年9月19日投资者关系活动记录表

Group 1: Investor Relations Activity - The meeting was categorized as an analyst meeting, with a focus on understanding the company's production and operational status [2] - Participants included representatives from various investment management companies, indicating a diverse interest in the company's performance [2] Group 2: Meeting Details - The meeting took place on September 19, 2025, at the company's headquarters [2] - Key personnel from the company included the board secretary and representatives from investor relations, highlighting the importance of the event [2] Group 3: Purpose of the Meeting - The primary objective was to gather insights into the company's operational conditions and address related inquiries from investors [2]